National Institutes of Health Director Dr. Jay Bhattacharya attempted to reassure members of Congress on both sides of the aisle on Tuesday that his biomedical research agency is on the right track.

People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Kennedy Jr.’s first year in the Trump administration racked up win after win for the longtime anti-vaccine crusaders ...

Health authorities have raised concern over a surge in genital warts cases in parts of Ghana, attributing the trend to ...

Jay Bhattacharya, NIH director and newly minted acting CDC head, has so far avoided much of the harsh criticism levied at ...

US aid cuts have left Kenya exposed to rising disease outbreaks, climate shocks, and ...

Lawyers for both sides in the federal lawsuit, brought by six medical organizations, are trying to understand the ...

The vaccine was previously approved in the US to prevent LRTD related to RSV infection in adults 60 years or older and ...

Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the ...

Eswatini joined a handful of countries to officially roll out new HIV prevention ​drug lenacapavir on Wednesday, announcing ...

Grammy-winning artist Ciara joins SXSW 2026 to raise awareness, reduce stigma, and educate women and communities about HIV ...